CVE-2022-30277
Last modified
CVE-2022-30277 is a medium-severity vulnerability rated 5.7/10 on the CVSS scale. BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).. EPSS estimates a 0.22% chance of exploitation in the next 30 days.
Description
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Metrics
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Bd | Synapsys | 4.20 |
| Bd | Synapsys | 4.30 |
References
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-30277?
How severe is CVE-2022-30277?
How do I fix CVE-2022-30277?
Are you affected by CVE-2022-30277?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
